Skip to main content

Table 4 Meta-analysis of outcomes according to maternal and treatments characteristics

From: Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis

 

Groups

ICU Admission

Hospital Length of Stay

Preterm Birth

Proportion

(95% CI)

Mean (95% CI)a

Proportion

(95% CI)

Treatment

 Oxygen support

≤ 0.25 (low)

0.03 (0.00, 0.08)

8.89 (4.31, 13.48)

0.20 (0.10, 0.33)

>  0.25 (high)

0.10 (0.02, 0.21)

9.10 (8.05, 10.15)

0.33 (0.21, 0.46)

 Steroids

Not given

0.06 (0.01, 0.15)

7.45 (2.22, 12.69)

0.29 (0.17, 0.42)

Given

0.06 (0.02, 0.11)

9.18 (6.49, 11.86)

0.27 (0.17, 0.37)

 Immunosuppressants

Not given

0.03 (0.01, 0.06)

7.75 (5.10, 10.41)

0.26 (0.18, 0.36)

Given

0.24 (0.05, 0.51)

12.37 (4.22, 20.52)

0.35 (0.13, 0.60)

 Hydroxychloroquine

≤ 0.043 (low)

0.02 (0.00, 0.05)

9.95 (6.24, 13.65)

0.30 (0.16, 0.46)

>  0.043 (high)

0.11 (0.04, 0.21)

7.30 (4.22, 10.38)

0.22 (0.15, 0.30)

 Antivirals

≤ 0.25 (low)

0.05 (0.02, 0.09)

8.84 (5.63, 12.05)

0.29 (0.16, 0.44)

>  0.25 (high)

0.07 (0.00, 0.20)

7.38 (4.67, 10.10)

0.25 (0.16, 0.34)

 Zinc/Magnesium

Not given

0.06 (0.02, 0.11)

8.34 (5.36, 11.32)

0.26 (0.18, 0.34)

Given

0.07 (0.03, 0.13)

NA

0.44 (0.30, 0.58)

 Anticoagulants

Not given

0.03 (0.02, 0.05)

8.10 (4.98, 11.23)

0.27 (0.18, 0.38)

Given

0.18 (0.03, 0.40)

9.24 (3.73, 14.74)

0.28 (0.14, 0.44)

 Antibiotics

≤ 0.23 (low)

0.04 (0.01, 0.06)

6.37 (3.49, 9.24)

0.22 (0.13, 0.32)

>  0.23 (high)

0.09 (0.02, 0.20)

10.44 (6.23, 14.65)

0.31 (0.20, 0.44)

 Plasma/Anti-Liver damage

Not given

0.06 (0.02, 0.11)

7.74 (5.26, 10.22)

0.28 (0.20, 0.36)

Given

0.04 (0.00, 0.22)

13.99 (9.27, 18.70)

0.17 (0.05, 0.32)

Cesarean section

≤ 0.51 (low)

0.06 (0.02, 0.12)

8.73 (5.11, 12.34)

0.21 (0.13, 0.30)

>  0.51 (high)

0.06 (0.00, 0.15)

7.95 (5.45, 10.45)

0.33 (0.20, 0.46)

Symptomatic

≤ 0.94 (low)

0.04 (0.01, 0.08)

7.62 (3.80, 11.45)

0.18 (0.15, 0.22)

>  0.94 (high)

0.10 (0.02, 0.22)

7.85 (5.17, 10.53)

0.38 (0.23, 0.54)

Comorbidities

 Diabetes mellitus

≤ 0.06 (low)

0.07 (0.02, 0.13)

8.32 (5.08, 11.55)

0.21 (0.14, 0.29)

>  0.06 (high)

0.08 (0.00, 0.22)

8.62 (4.42, 12.82)

0.39 (0.19, 0.61)

 Hypertension

≤ 0.03 (low)

0.11 (0.01, 0.27)

10.81 (6.60, 15.01)

0.27 (0.12, 0.44)

>  0.03 (high)

0.04 (0.02, 0.07)

6.76 (4.54, 8.98)

0.32 (0.18, 0.47)

 Asthma

≤ 0.034 (low)

0.07 (0.00, 0.22)

9.97 (5.63, 14.30)

0.35 (0.19, 0.53)

>  0.034 (high)

0.07 (0.03, 0.13)

7.28 (3.95, 10.62)

0.24 (0.11, 0.40)

 Obesity

≤ 0.10 (low)

0.04 (0.01, 0.08)

7.71 (3.58, 11.85)

0.42 (0.10, 0.78)

>  0.10 (high)

0.13 (0.03, 0.29)

8.25 (4.37, 12.13)

0.33 (0.15, 0.53)

  1. aWeighted mean reported; ICU intensive care unit, CI confidence interval, NA not available; bold values indicate a significant presence (at least 5%) of the condition relative to their average value